Brief: Pharming Sells Priority Review Voucher To Novartis

Pharming

01/06/2023 06:01

June 1 (Reuters) - Pharming Group NV  PHAR.AS :
    * PHARMING ANNOUNCES SALE OF PRIORITY REVIEW VOUCHER
    * SALE FOR A PRE-AGREED, ONE-TIME PAYMENT OF APPROXIMATELY
US$21.1
MILLION SHORTLY AFTER CLOSING
    * DEFINITIVE AGREEMENT WITH NOVARTIS PHARMA A.G.  TO SELL
ITS RARE
PEDIATRIC DISEASE PRIORITY REVIEW VOUCHER (PRV)

Source text for Eikon:  ID:nPn5JCrg2a 
Further company coverage:  PHAR.AS 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))